Related Experiment Videos
Hormonal status in postmenopausal androgenetic alopecia
S Georgala1, K Gourgiotou, S Kassouli
1Department of Dermatology, University of Athens, Greece.
International Journal of Dermatology
|December 1, 1992
Summary
This study found no significant differences in hormone levels between postmenopausal women with androgenetic alopecia and controls. This suggests that hair follicle androgen receptor alterations, not systemic hormone levels, may cause female pattern hair loss.
Area of Science:
- Endocrinology
- Dermatology
- Genetics
Background:
- Androgenetic alopecia is linked to increased androgen activity in hair follicles, particularly after menopause.
- The precise hormonal mechanisms driving female pattern hair loss remain incompletely understood.
Purpose of the Study:
- To investigate serum levels of testosterone, estradiol, and sex hormone-binding globulin (SHBG) in postmenopausal women with androgenetic alopecia.
- To compare these hormone levels with those of age- and sex-matched healthy controls.
Main Methods:
- Serum samples were collected from ten postmenopausal women diagnosed with androgenetic alopecia.
- Serum samples were also collected from ten healthy, age- and sex-matched postmenopausal women.
- Levels of testosterone, estradiol, and SHBG were measured in all participants.
Main Results:
- No statistically significant differences were observed in serum testosterone, estradiol, or SHBG levels between the androgenetic alopecia group and the control group.
- This indicates that systemic hormonal imbalances are unlikely to be the primary cause of androgenetic alopecia in these postmenopausal women.
Conclusions:
- The findings suggest that androgenetic alopecia in postmenopausal women may stem from genetically determined functional changes in androgen receptors within hair follicle keratinocytes.
- Alternatively, a localized metabolic disturbance in the hair follicle's keratinocytes could contribute to the condition.